chronic Graft versus Host Disease
Showing 26 - 50 of >10,000
Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor, Refractory Sclerodermatous GVHD Trial in Duarte (procedure,
Not yet recruiting
- Hematopoietic and Lymphoid System Neoplasm
- +2 more
- Biospecimen Collection
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 23, 2022
Sclerodermoid Chronic GVHD (Disorder) Trial in Spain (Glasdegib)
Active, not recruiting
- Sclerodermoid Chronic Graft-Versus-Host Disease (Disorder)
-
Barcelona, Spain
- +5 more
Mar 16, 2022
Chronic Graft-versus-host Disease (cGVHD) Trial in Aventura (AMG 592, Placebo)
Completed
- Chronic Graft-versus-host Disease (cGVHD)
- AMG 592
- Placebo
-
Aventura, FloridaResearch Site
May 16, 2023
GVHD Trial run by the NHLBI (Topical Dexamethasone, Placebo)
Completed
- Graft vs Host Disease
- Topical Dexamethasone
- Placebo
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 20, 2022
Chronic Graft-versus-Host Disease (cGVHD) Trial in Randwick (AMG 592, Placebo)
Completed
- Chronic Graft-versus-Host Disease (cGVHD)
- AMG 592
- Placebo
-
Randwick, New South Wales, AustraliaResearch Site
May 23, 2023
Chronic GVHD Trial in Boston (Abatacept)
Active, not recruiting
- Chronic Graft Versus Host Disease
-
Boston, Massachusetts
- +1 more
Jan 25, 2022
Chronic GVHD Trial in Sevilla (Regulatory T-cell enriched infusion)
Recruiting
- Chronic Graft vs Host Disease
- Regulatory T-cell enriched infusion
-
Sevilla, SpainJosé Antonio Pérez Simón
May 20, 2022
GVHD Trial in United States (Belumosudil (KD025))
Completed
- Graft vs Host Disease
- Belumosudil (KD025)
-
Duarte, California
- +6 more
May 27, 2022
Chronic GVHD, Chronic Graft-Versus-Host-Disease, Bronchiolitis Obliterans Syndrome Trial run by the National Cancer Institute
Recruiting
- Chronic Graft vs Host Disease
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 18, 2022
Microbiota Composition With cGVHD After Allo-HSCT
Recruiting
- Hematopoietic Stem Cell Transplantation
- +3 more
- blood sample
- stool sample
-
Hangzhou, Zhejiang, China
- +9 more
Jul 31, 2022
Graft Vs Host Disease Trial in Shenzhen (Umbilical Cord Mesenchymal Stem Cell Therapy)
Recruiting
- Graft Vs Host Disease
- Umbilical Cord Mesenchymal Stem Cell Therapy
-
Shenzhen, Guangdong, ChinaLi Yu
Dec 4, 2021
Hematopoietic Stem Cell Transplantation, Multiple Myeloma Trial in Spain (Ixazomib, Tacrolimus, Sirolimus)
Recruiting
- Hematopoietic Stem Cell Transplantation
- Multiple Myeloma
- Ixazomib
- +3 more
-
Badalona, Spain
- +7 more
May 20, 2022
Chronic Graft-versus-host-disease Trial in United States (SNDX-6352)
Active, not recruiting
- Chronic Graft-versus-host-disease
-
Birmingham, Alabama
- +10 more
Aug 18, 2022
A Prospective Observational Study for Evaluating CGVHD
Completed
- Chronic Graft-Versus-Host Disease
-
Alessandria, Italy
- +26 more
Nov 23, 2022
GVHD, GVHD, Undefined Trial in United States (Photobiomodulation Therapy, Placebo sham device)
Recruiting
- Graft-Versus-Host Disease
- +2 more
- Photobiomodulation Therapy
- Placebo sham device
-
Bethesda, Maryland
- +8 more
Jan 17, 2023
Oral Lichen Planus, Mucous Membrane Pemphigoid, Pemphigus Vulgaris Trial in San Francisco (dexamethasone 0.5mg/5ml solution,
Completed
- Oral Lichen Planus
- +3 more
- dexamethasone 0.5mg/5ml solution
- dexamethasone 0.5mg/5ml solution in Mucolox™
-
San Francisco, CaliforniaSol Silverman Oral Medicine Clinic - UCSF
Jan 6, 2023
Mapping for Detection of Chronic Lung Injury in Hematopoietic
Recruiting
- Chronic Lung Disease
- +2 more
-
Ann Arbor, MichiganThe University of Michigan Cancer Center
May 9, 2023
Chronic GVHD Trial in Ann Arbor, Salt Lake City (Laboratory Biomarker Analysis, Vismodegib)
Terminated
- Chronic Graft Versus Host Disease
- Laboratory Biomarker Analysis
- Vismodegib
-
Ann Arbor, Michigan
- +1 more
Jun 22, 2021
Pediatric cGVHD Symptom Scale
Recruiting
- Graft vs Host Disease
-
Aurora, Colorado
- +11 more
Jan 27, 2023
Chronic GVHD Trial in Seattle (Immunosuppressive Therapy, Survey Administration)
Completed
- Chronic Graft Versus Host Disease
- Immunosuppressive Therapy
- Survey Administration
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 22, 2021
Chronic Graft-versus-host-disease Trial in Goyang-si, Incheon, Seoul (SCM-CGH, Placebo)
Recruiting
- Chronic Graft-versus-host-disease
- SCM-CGH
- Placebo
-
Goyang-si, Gyeonggi-do, Korea, Republic of
- +6 more
Sep 26, 2021